Form D · Other Health Care
Acera, Inc.
Annapolis, MD · CIK 0001602312
Offering snapshot reported Mar 13, 2014 · SEC filing
- Reported sold
- $50K Offering amount: $250K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Feb 26, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 13, 2014 | Initial | $50,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-213508
Source: Form D, filed Mar 13, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael S. Epstein | Director, Executive |
| Thomas V. Root | Director, Executive |
| Kimberly D. Williams | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
621 Ridgely Ave., Suite 204
Annapolis, MD, 21014
Annapolis, MD, 21014